Patent · US Active

Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

US8802689B2 · kind B2 · utility

24Cited by
52References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 13, 2012
Grant dateAug 12, 2014
Priority date—
Expiry dateSep 13, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein, inter alia, are compounds useful for the prevention or treatment of hyperproliferative diseases or disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.